The effects of COVID-19 on liver enzymes are still being studied, but there is some evidence that the virus can affect the liver. The coronavirus is known to cause damage to the lungs and other organs, and it is possible that it may also affect the liver.
Several studies have reported abnormal liver enzyme levels in patients with COVID-19. A study conducted in China found that around 30% of patients with COVID-19 had elevated levels of alanine aminotransferase (ALT), which is an enzyme produced by the liver. Another study reported that around 40% of patients with severe COVID-19 had elevated levels of aspartate aminotransferase (AST), another enzyme produced by the liver.
Although the exact mechanism by which COVID-19 affects the liver is still unknown, it is thought to be related to the inflammatory response caused by the virus. The virus triggers an inflammatory response in the body, which can lead to damage to liver cells and an increase in liver enzymes. It is also possible that the virus can directly infect the liver, leading to further damage.
It is important to note that elevated liver enzymes can also be caused by other factors, such as medications, alcohol, and other infections. Therefore, it is important for patients with COVID-19 to have their liver enzymes monitored and tested to ensure that they are not due to any other underlying cause.
In conclusion, there is evidence that COVID-19 can affect liver enzymes. However, further research is needed to understand the exact mechanisms by which this occurs. In the meantime, it is important for patients with COVID-19 to have their liver enzymes monitored closely to ensure that any elevation is not due to another underlying cause.